Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial encephalomyopathy with 15915 mutation: clinical report

A Seki1, I Nishino, Y Goto

  • 1Division of Child Neurology; Institute of Neurological Sciences; Faculty of Medicine; Tottori University; Japan.

Pediatric Neurology
|November 21, 1997
PubMed
Summary

This study details a novel mitochondrial DNA mutation causing encephalomyopathy in a teen. Combined Coenzyme Q10 (CoQ10) and idebenone therapy halted disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of cutis verticis gyrata is associated with c.1279_1290del12 of SLCO2A1 in 43 Japanese patients with pachydermoperiostosis.

Journal of dermatological science·2024
Same author

Haematological inflammatory markers for indicating ischemic bowel in patients with incarcerated abdominal wall hernias.

Hernia : the journal of hernias and abdominal wall surgery·2021
Same author

Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.

Neuropathology and applied neurobiology·2020
Same author

Sweat retention anhidrosis associated with tubular aggregate myopathy.

The British journal of dermatology·2019
Same author

Absence of sarcoplasmic myxovirus resistance protein A (MxA) expression in antisynthetase syndrome in a cohort of 194 cases.

Neuropathology and applied neurobiology·2019
Same author

Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis.

Neuropathology and applied neurobiology·2018

Area of Science:

  • Mitochondrial Medicine
  • Neurogenetics
  • Biochemistry

Background:

  • Mitochondrial encephalomyopathy presents with diverse neurological and muscular symptoms.
  • Genetic mutations in mitochondrial DNA (mtDNA) are a key cause of these disorders.
  • Identifying specific mutations is crucial for understanding disease mechanisms and developing treatments.

Observation:

  • A 16-year-old male exhibited seizures, short stature, muscle weakness, hearing loss, intellectual disability, and myoclonus.
  • Cranial CT revealed basal ganglia calcification and cerebral atrophy.
  • Muscle biopsy showed ragged-red fibers and altered enzyme activity, indicative of mitochondrial dysfunction.

Findings:

  • A novel point mutation was identified in the tRNA-Thr gene of the mitochondrial DNA (mtDNA) at position 15915.

Related Experiment Videos

  • High-dose Coenzyme Q10 (CoQ10) therapy reduced serum lactate levels.
  • Combined CoQ10 and idebenone administration stabilized clinical symptoms for 16 months, improving EEG spectral power density.

    • Implications:

    • This research identifies a new mtDNA mutation linked to mitochondrial encephalomyopathy.
    • Coenzyme Q10 and idebenone show therapeutic potential for this specific genetic disorder.
    • Further research into CoQ10 and idebenone may offer new treatment strategies for mitochondrial diseases.